[Home]
[Full version]
Prescription labels geared toward pharmacies, not patients
Sep 11 ,Medicine & Health
The labels on most prescription drug containers highlight the pharmacy’s name or logo rather than instructions on how to take the medication, reports a new study in the September 10 issue of the Archives of Internal Medicine.
The Institute of Medicine estimates that 1.5 million medication errors occur each year in the United States and poor labeling is one cause of the mistakes. While the Food and Drug Administration has some standards on what prescription labels must include, few regulations guide the format of the information, said lead author William Shrank, M.D., of Brigham and Women’s Hospital at Harvard Medical School
In the study, six pharmacies in four cities filled identically written prescriptions for four commonly prescribed medications. The pharmacies included the two largest chains, two grocery stores and two independent pharmacies.
Shrank, who is with the Division of Pharmacoepidemiology and Pharmacoeconomics, and colleagues evaluated 85 labels. The researchers found the pharmacy name or logo was the most prominent item on 84 percent of the labels, with an average 13.6-point font size. By comparison, the instructions averaged a 9.3-point size and medication names averaged an 8.9-point font. Warning stickers were in a much smaller, 6.5-point font on average.
“Medical education guidelines explicitly suggest that font size must be 12 point or larger to optimize patients’ ability to read health information,” according to the authors.
All of the labels listed the pharmacy name first, and instructions appeared fifth on 89 percent of labels. When color font or boldface was present, it was most often for pharmacy information rather than for instructions or warnings.
The authors suggest that one way to improve readability and patient understanding of labels is for FDA to initiate a national standard for their format and content — much like it did with the “Nutrition Facts” labels required on food packaging.
“The FDA has attempted to improve drug labels on numerous occasions over the last three decades without much success,” Shrank said. “However, I believe that the growing concern regarding prescription drug safety and the greater role of the government in paying for drugs since [the introduction of] Medicare Part D, may provide an environment conducive to policy change.”
However, Jennifer Athay, a staff pharmacist with the American Pharmacists Association, said that it would be very difficult to have a federally mandated, standardized label required across the board.
“Logistically, there is no way to get all the information someone needs to know on a little prescription bottle or tube,” she said. “Size tends to be an issue, so the complete information you need to know is dispensed in the extra paperwork you get from the pharmacists.” She added that patients should ideally get detailed information when physicians first prescribe the medication to them.
Source: Center for the Advancement of Health
Related stories:
New reasons to avoid grapefruit and other juices when taking certain drugs
Scientists and consumers have known for years that grapefruit juice can increase the absorption of certain drugs — with the potential for turning normal doses into toxic overdoses. Now, the researcher who first identified this interaction is reporting new evidence that grapefruit and other common fruit juices, including orange and apple, can do the opposite effect by substantially decreasing the absorption of other drugs, potentially wiping out their beneficial effects.
Energy drinks linked to risk-taking behaviors among college students
Over the last decade, energy drinks -- such as Red Bull, Monster and Rockstar -- have become nearly ubiquitous on college campuses. The global market for these types of drinks currently exceeds $3 billion a year and new products are introduced annually.
Some drugs increase risk of falling
Researchers at the University of North Carolina at Chapel Hill have created a list of prescription drugs that increase the risk of falling for patients aged 65 and older who take four or more medications on a regular basis.
Hormonal dietary supplements might promote prostate cancer progression
Hormonal components in over-the-counter dietary supplements may promote the progression of prostate cancer and decrease the effectiveness of anti-cancer drugs, researchers at UT Southwestern Medical Center have discovered.
Tips to prevent adverse drug events in older adults
Adverse drug events are more common in older adults because they are prescribed more drugs and are effected differently by these drugs than their younger counterparts. A review article written by Tufts University School of Medicine clinicians, published in American Family Physician, summarizes steps that physicians and other healthcare providers can take to avoid overuse, misuse, and underuse of medication in older adults.
Soy estrogens and breast cancer: Researcher offers overview
Are soy products healthy additions to a person's diet, safe alternatives to hormone-replacement therapy or cancer-causing agents" The answer, according to University of Illinois food science and human nutrition professor William Helferich, is, "It depends."
Apple fans greet new technologies
Step into the Moscone Center on the third day of Macworld Expo and it'd be hard to argue that this computer platform controls only 5 percent of the overall computer market. Throngs of users, sometimes three to five deep, line up in the Apple Computer booth to go hands-on with Apple's recently introduced iMac Core Duo desktop and MacBook Pro laptop, both based on Intel microprocessors.
SAP, Infineon Ease Integration of RFID Hardware and Software
SAP AG and
Infineon Technologies AG today announced a new radio frequency identification (RFID) offering to meet companies’ needs to connect and manage
RFID hardware and software from multiple vendors. Based on the SAP NetWeaver™ technology platform and Infineon’s RFID You-R® OPEN (OPerating ENvironment) device integration platform, the new offering will help companies deploy RFID hardware, devices, tags and software components for RFID-enabled business processes while accelerating return on investment and reducing integration costs and risks.
[Home]
[Full version]